Durvalumab
Stock Recap #PipelineProspector

Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

As summer draws to a close, pharma and biotech indices posted their fourth consecutive month in the

Pipeline Prospector April 2024: Indices dip amid muted Q1 results; Vertex acquires Alpine Immune for US$ 4.9 bn

Pharma indices had begun to recede in March. Their red streak accelerated in April with the Nasdaq B

Biotech indices inch up post SVB bloodbath; Covid drugmakers report drop in Q1 sales

In March, the collapse of Silicon Valley Bank (SVB) had dragged the biotech indices down. SVB had ma

Pipeline Prospector Feb 2023: Low demand for Covid drugs hammers down Lilly, Moderna stocks

The year had opened on a buoyant note. But February quickly dashed any hopes of a market rebound and